JACC: Case Reports (Jul 2024)

High-Output Heart Failure in Multiple Myeloma

  • Enklajd Marsela, MD,
  • Eric Hirsch, MD,
  • Leandro Slipczuk, MD, PhD,
  • Mark I. Travin, MD,
  • Renée M. Moadel, MD, MS,
  • Ulrich P. Jorde, MD,
  • Sasa Vukelic, MD, PhD

Journal volume & issue
Vol. 29, no. 14
p. 102387

Abstract

Read online

We introduce the innovative use of technetium-99m–labeled macroaggregated albumin to diagnose high-output heart failure in a patient with multiple myeloma with persistent congestion symptoms. Symptom resolution occurred with lenalidomide and steroids. This marks the first clinical use of technetium-99m–labeled macroaggregated albumin for clarifying high-output heart failure etiology.

Keywords